Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor B (SIII) pseudogene (ENSG00000229629) is a non-protein-coding pseudogene in the human genome that shares sequence homology with the functional transcription elongation factor B (SIII), specifically the elongin B subunit encoded by the functional ELOB gene[2][4][5]. By definition, pseudogenes are genetic sequences that resemble functional genes but have accumulated mutations that disrupt their coding potential, and they do not encode functional proteins[3]. This pseudogene is identified primarily through computational annotation and has no known biological or clinical relevance as a drug target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription elongation factor B (SIII) pseudogene (None).